| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Original Articles |
From the City of Hope National Medical Center (DZJC), Duarte, California; Southwest Oncology Group Statistical Center (KC), Seattle, Washington; University of Arizona Cancer Center (DSA), Tucson, Arizona; University of California (FLM), Irvine, Orange, California; University of Cincinnati Medical Center (CMF-P), Cincinnati, Ohio; Puget Sound Oncology Consortium (SER, GEG), Seattle, Washington; Louisiana State University (GMM), Shreveport, Louisiana; Greenville Community Clinical Oncology Program (JKG), Greenville, South Carolina; and M. D. Anderson Cancer Center (JLA, SML), Houston, Texas.
Address correspondence and reprint requests to: Southwest Oncology Group (SWOG-9041) Operations Office, 14980 Omicron Drive, San Antonio, TX 78245-3217.
| Abstract |
|---|
Background: Colorectal adenomas are the usual precursors to carcinoma in sporadic and hereditary colorectal cancers (CRC).
Methods: A total of 220 CRC patients (stages 0, I, and II) were randomized prospectively in a double-blind pilot study of calcium chemoprevention by using recurrent colorectal adenomas as a surrogate end point. This trial is still in progress, and we report the preliminary findings on adenoma recurrence rates.
Results: Synchronous adenomas were present in 60% of patients, and cancer confined in a polyp was present in 23% of patients. The overall cumulative adenoma recurrence rate was 31% (19% in the first year, 29% for 2 years, and 35% for 3 years). The recurrence rates were greater for patients with synchronous adenomas: 38% at 3 years (P = .01). Lower stage was associated with higher adenoma recurrence rates (P = .04). Factors including age, sex, site of primary cancer, and whether the cancer was confined to a polyp were not significantly associated with differences in adenoma recurrence rates.
Conclusions: The substantial adenoma recurrence rate in patients resected of CRC justifies colonoscopic surveillance on a periodic basis. Patients with higher rates of adenoma recurrences, such as CRC with synchronous adenomas, are ideal subjects for chemoprevention trials.
Key Words: Adenoma, Colorectal cancer, Synchronous adenoma, Adenoma recurrence rate.
This article has been cited by other articles:
![]() |
M. M. Bertagnolli Colorectal Cancer Prevention Studies: The Importance of Defining Disease Risk Ann. Surg. Oncol., October 1, 2003; 10(8): 829 - 830. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |